8-K: Hawkins, Inc. Reports Record Third Quarter Fiscal 2025 Results Driven by Water Treatment Segment

Hawkins, Inc. announces record third quarter fiscal 2025 results, fueled by significant growth in its Water Treatment segment.

Summary

• Hawkins, Inc. reported record third quarter results for fiscal year 2025, with revenue, gross profit, operating income, and adjusted EBITDA reaching new highs.
• Overall revenue increased by 8%, primarily driven by a 22% growth in the Water Treatment segment.
• Gross profit grew by 15%, with double-digit percentage growth in both the Water Treatment and Health and Nutrition segments.
• Operating income reached $21.1 million, marking the 27th consecutive quarter of year-over-year growth.
• Diluted earnings per share (EPS) were $0.72, compared to $0.71 in the prior year, which was positively impacted by an unusual favorable tax adjustment of $0.08 per share.
• Adjusted EBITDA, a non-GAAP measure, increased by 13% to $33.6 million, with a trailing 12-month adjusted EBITDA of $162 million.
• Year-to-date revenue was up 5% and EPS was up 11% compared to the prior year.
• The company's leverage ratio was 0.7x trailing 12-month proforma adjusted EBITDA at the end of the quarter.
• Hawkins expects continued growth in the Water Treatment and Health and Nutrition segments, while the Industrial segment is expected to perform similarly to the first nine months of fiscal 2025.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with record financial results and strong growth in key segments. The management's comments are optimistic, and the balance sheet appears healthy. However, there are some concerns about the Industrial segment and increased expenses, preventing a higher score.

Positives

• Record third quarter results across key financial metrics.
• Strong growth in the Water Treatment segment, driven by acquisitions and organic volume growth.
• Double-digit percentage growth in gross profit for both the Water Treatment and Health and Nutrition segments.
• Consistent operating income growth for 27 consecutive quarters.
• Strong balance sheet with a manageable leverage ratio of 0.7x trailing 12-month proforma adjusted EBITDA.
• Health and Nutrition revenues increased due to growth of manufactured product sales.
• Cash dividends declared per common share increased from $0.16 to $0.18.

Negatives

• Industrial segment sales decreased by 1% due to lower selling prices driven by lower commodity costs and product mix.
• Diluted earnings per share (EPS) only slightly increased from $0.71 to $0.72, with the prior year being positively impacted by an unusual favorable tax adjustment of $0.08 per share.
• Selling, general and administrative expenses increased $3.6 million, or 15%, to $27.4 million, or 12% of sales, for the current quarter, from $23.8 million, or 11% of sales, in the same period a year ago.

Risks

• Changes in competition and price pressures could affect future financial results.
• Changes in demand and customer requirements or processes for products may impact performance.
• Disruptions to supplies, interruptions in production, and transportation limitations could negatively impact the business.
• Changes in imported products and tariff levels could affect the availability and prices of products.
• The acceptance of new products by customers and the timing of such acceptance are uncertain.
• Changes in product supplies could impact the business.

Future Outlook

Hawkins expects continued growth within the Water Treatment and Health and Nutrition segments, while the Industrial segment is expected to perform similarly to the first nine months of fiscal 2025.

Management Comments

• Patrick H. Hawkins, Chief Executive Officer and President, stated that the record performance was driven by the Water Treatment business, benefiting from recent acquisitions.
• Mr. Hawkins noted strong revenue growth of 22% in the Water Treatment business, with 9% organic volume growth.
• Mr. Hawkins mentioned that the balance sheet continues to be strong and that net borrowings helped fund the acquisition of Water Guard.
• Mr. Hawkins stated that the company expects continued growth within the Water Treatment and Health and Nutrition segments.

Industry Context

Hawkins' focus on water treatment aligns with increasing global concerns about water quality and scarcity, positioning the company to capitalize on growing demand for water treatment solutions. The health and nutrition segment also benefits from increasing consumer awareness of health and wellness.

Comparison to Industry Standards

• Comparing Hawkins to similar specialty chemical and water treatment companies like Ecolab or Axalta Coating Systems, Hawkins' revenue growth in the Water Treatment segment appears competitive.
• Hawkins' adjusted EBITDA margin of approximately 15% (based on $33.6 million adjusted EBITDA on $226.2 million sales) is within the range of its peers.
• The leverage ratio of 0.7x trailing 12-month proforma adjusted EBITDA suggests a conservative financial position compared to some more highly leveraged companies in the sector.

Stakeholder Impact

• Shareholders will likely react positively to the record financial results and growth prospects.
• Employees may benefit from the company's success through potential bonuses and career opportunities.
• Customers can expect continued quality products and services.
• Suppliers may see increased demand for their products.
• Creditors are likely to view the company's financial position favorably.

Key Dates